Gene therapy for Wiskott-Aldrich Syndrome-Long-term reconstitution and clinical benefits, but increased risk for leukemogenesis.
about
Gene therapy for Wiskott-Aldrich Syndrome-Long-term reconstitution and clinical benefits, but increased risk for leukemogenesis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Gene therapy for Wiskott-Aldri ...... eased risk for leukemogenesis.
@ast
Gene therapy for Wiskott-Aldri ...... eased risk for leukemogenesis.
@en
type
label
Gene therapy for Wiskott-Aldri ...... eased risk for leukemogenesis.
@ast
Gene therapy for Wiskott-Aldri ...... eased risk for leukemogenesis.
@en
prefLabel
Gene therapy for Wiskott-Aldri ...... eased risk for leukemogenesis.
@ast
Gene therapy for Wiskott-Aldri ...... eased risk for leukemogenesis.
@en
P2093
P2860
P1476
Gene therapy for Wiskott-Aldri ...... eased risk for leukemogenesis.
@en
P2093
Anna Paruzynski
Christoph Klein
Kaan Boztug
Manfred Schmidt
Maximilian Witzel
P2860
P304
P356
10.4161/21675511.2014.947749
P577
2014-10-30T00:00:00Z